Companies / X4 Pharmaceuticals, Inc / Activity
Activity — X4 Pharmaceuticals, Inc
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | Kirske David Executive | Sell | Common Stock | $72.8K | -17K -8.78% | 176,293 0.18% of shares | low |
| Jan 1, 2026 | Stewart Murray Director | Grant | Stock Option (right to buy) | — | +110K | 0 0.00% of shares | low |
| Jan 1, 2026 | Bridger Gary Director | Grant | Stock Option (right to buy) | — | +110K | 0 0.00% of shares | low |
| Jan 1, 2026 | de Craecker Francoise Director | Grant | Stock Option (right to buy) | — | +110K | 0 0.00% of shares | low |
| Jan 1, 2026 | Wyzga Michael S Director | Grant | Stock Option (right to buy) | — | +110K | 0 0.00% of shares | low |